Strategic Wealth Partners Ltd. Decreases Stock Holdings in Philip Morris International Inc. (NYSE:PM)

Share on StockTwits

Strategic Wealth Partners Ltd. lowered its stake in shares of Philip Morris International Inc. (NYSE:PM) by 21.6% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 507 shares of the company’s stock after selling 140 shares during the period. Strategic Wealth Partners Ltd.’s holdings in Philip Morris International were worth $39,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently added to or reduced their stakes in the company. Payden & Rygel raised its position in Philip Morris International by 20.2% during the second quarter. Payden & Rygel now owns 389,200 shares of the company’s stock worth $30,564,000 after acquiring an additional 65,400 shares during the last quarter. Meristem Family Wealth LLC acquired a new position in Philip Morris International during the second quarter worth about $638,000. Lincoln National Corp raised its position in Philip Morris International by 38.2% during the second quarter. Lincoln National Corp now owns 9,503 shares of the company’s stock worth $746,000 after acquiring an additional 2,628 shares during the last quarter. Mid Atlantic Financial Management Inc. ADV raised its position in Philip Morris International by 2.2% during the second quarter. Mid Atlantic Financial Management Inc. ADV now owns 12,861 shares of the company’s stock worth $1,010,000 after acquiring an additional 279 shares during the last quarter. Finally, IFG Advisory LLC raised its position in Philip Morris International by 2.5% during the second quarter. IFG Advisory LLC now owns 16,866 shares of the company’s stock worth $1,324,000 after acquiring an additional 417 shares during the last quarter. 74.33% of the stock is currently owned by hedge funds and other institutional investors.

Shares of NYSE:PM traded down $1.73 during trading on Friday, reaching $81.22. The stock had a trading volume of 2,923,273 shares, compared to its average volume of 4,566,205. The business has a fifty day moving average price of $83.53 and a 200-day moving average price of $83.74. The stock has a market cap of $129.06 billion, a P/E ratio of 15.93, a PEG ratio of 2.02 and a beta of 0.96. Philip Morris International Inc. has a fifty-two week low of $64.67 and a fifty-two week high of $92.74.

Philip Morris International (NYSE:PM) last posted its quarterly earnings data on Thursday, July 18th. The company reported $1.46 earnings per share for the quarter, beating analysts’ consensus estimates of $1.33 by $0.13. The business had revenue of $7.70 billion during the quarter, compared to analyst estimates of $7.42 billion. Philip Morris International had a net margin of 10.03% and a negative return on equity of 80.96%. The company’s revenue was down .3% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.41 earnings per share. Equities analysts anticipate that Philip Morris International Inc. will post 5.22 earnings per share for the current fiscal year.

A number of equities analysts have issued reports on PM shares. Zacks Investment Research upgraded shares of Philip Morris International from a “sell” rating to a “hold” rating in a research report on Thursday, May 23rd. Bank of America upgraded shares of Philip Morris International from an “underperform” rating to a “neutral” rating and lifted their target price for the stock from $81.00 to $94.00 in a research report on Friday, May 17th. Societe Generale upgraded shares of Philip Morris International from a “hold” rating to a “buy” rating in a research report on Tuesday, May 7th. ValuEngine cut shares of Philip Morris International from a “hold” rating to a “sell” rating in a research report on Thursday, August 1st. Finally, Barclays upgraded shares of Philip Morris International from an “equal weight” rating to an “overweight” rating and lifted their target price for the stock from $82.00 to $100.00 in a research report on Friday, July 19th. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating and eight have issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of $93.92.

In other news, insider Mario Masseroli sold 1,100 shares of the business’s stock in a transaction that occurred on Tuesday, July 23rd. The shares were sold at an average price of $87.42, for a total value of $96,162.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, VP Michael R. Kunst acquired 500 shares of the business’s stock in a transaction dated Wednesday, May 29th. The stock was purchased at an average cost of $80.74 per share, with a total value of $40,370.00. The disclosure for this purchase can be found here. Insiders own 0.21% of the company’s stock.

Philip Morris International Profile

Philip Morris International Inc, through its subsidiaries, manufactures and sells cigarettes, other nicotine-containing products, and smoke-free products and related electronic devices and accessories. The company offers IQOS smoke-free products, including heated tobacco and nicotine-containing vapor products under the HEETS, HEETS Marlboro, and HEETS FROM MARLBORO brands, as well as the Marlboro HeatSticks and Parliament HeatSticks brands.

Featured Story: Marijuana Stocks

Institutional Ownership by Quarter for Philip Morris International (NYSE:PM)

Receive News & Ratings for Philip Morris International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Philip Morris International and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Greencore Group’s  Hold Rating Reiterated at Peel Hunt
Greencore Group’s Hold Rating Reiterated at Peel Hunt
GlaxoSmithKline  Given “Equal weight” Rating at Barclays
GlaxoSmithKline Given “Equal weight” Rating at Barclays
Bank of America Analysts Give GlaxoSmithKline  a GBX 1,900 Price Target
Bank of America Analysts Give GlaxoSmithKline a GBX 1,900 Price Target
HSBC Analysts Give International Consolidated Airlns Grp  a GBX 460 Price Target
HSBC Analysts Give International Consolidated Airlns Grp a GBX 460 Price Target
IMI  Coverage Initiated by Analysts at Berenberg Bank
IMI Coverage Initiated by Analysts at Berenberg Bank
ITV’s  “Buy” Rating Reiterated at Liberum Capital
ITV’s “Buy” Rating Reiterated at Liberum Capital


© 2006-2019 Ticker Report